TSE:MFC

Manulife Financial (MFC.TO)

57.19
+0.15 (0.26%)
as of Jun 26, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 26, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed reviews from experts, reflecting a range of perspectives on its current standing and future potential. Several analysts highlight the company's strong dividend yield and its robust performance in Asia, suggesting it may be a worthwhile long-term investment, particularly for those seeking income rather than growth. However, concerns regarding earnings fluctuations, market pullbacks, and comparisons with peers like Sun Life Financial indicate that MFC may not be as attractive as other options in the life insurance sector. Many experts recognize the potential for capital appreciation, yet they caution that the stock faces headwinds, especially when considering broader market dynamics and the performance of similar financial institutions. There is a prevailing sentiment that the stock remains a reliable choice, albeit needing careful monitoring amidst potential market corrections.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
WAIT
Has looked at insurance companies and concluded that MFC is the one they will probably double up on, but not now. If you look out 2 to 3 years then it is an excellent buy.
BUY
Doing poorly this year. Have a lot of leverage to earnings and higher interest rates in a better stock market. Earnings will probably not be very good for 2nd quarter. However, trading at a discount to book value so it is an attractive buy. Good with a 3 to 5 year time horizon.
WAIT
Used to own it. Didn’t because of hedged position. He is concerned with how fast they can build up their hedge to 70%. Then he will look at the stock
DON'T BUY
A really bad looking chart. He doesn’t touch it any more. It is making new lows. It could drop to the $14 point.
PAST TOP PICK
4.896% bonds maturing 6/2/14. (Top Pick Jun 2/09, Up 9.19%) Recently sold.
BUY ON WEAKNESS
Very, very exposed to what happens in the equity markets. Longer term, it will prove to be a good investment, especially from these levels. Don’t look for return if time horizon is less than 2 years.
BUY
Doesn’t know if it is a potential takeover target. Likes the story and international market expansion. They are more covered now than during the recession. Great international expansion opportunities. No new buying interest. Canadian financials are a little more expensive than international.
TOP PICK
Did a ton of equity and debt issues so it was diluted over the last couple of years. Capital ratio (for insurance companies) is about 250%, really high. Have a growth profile in Asia. Really cheap at less than 1X Book. Looking for $30 in 2 years.
COMMENT
Big part of its job is investing its premiums in the stock market that sometimes doesn't work. You could consider holding this on a longer-term basis.
BUY
Manulife (MFC-T) or Power Financial (PWF-T)? If you have a long-term horizon such as 3 years and a higher tolerance of volatility, she would choose Manulife, which has a very attractive valuation of 1.1X Book.
HOLD
Strategy of the last president didn’t work. New management did a great job, but so what. People have to see the earnings. If the rest of the year is ok then the market may get more comfortable with the name. You have to be patient. He thinks the earnings are going to be there. Stick with it. You could start nibbling.
BUY ON WEAKNESS
Largest Canadian insurer. Hit because of high sensitivity to equity markets. With the value that is embedded in the insurance book and the growth potential in Asia, there is a lot of upside in the long-term. Well capitalized. You could Buy now or look for a 5%-10% further drop.
DON'T BUY
If he could pick a stock at the bottom of the market, this would probably be the one because it remains a levered play on the stock market. Has enormous exposure to index linked insurance annuities. If market craters you can look to this one getting really hit but when the market turns it should outperform.
COMMENT
Reported great 1st quarter earnings and announced it on the same day the market went down. There will probably be some resistance even when the market gets better and will struggle to get through $19. Likes their exposure to China. A long-term hold.
DON'T BUY
It turned down and looked like it would recover, but suddenly it fell below the 200-day moving average. If it breaks below $17 you are looking at a $10 stock.
Showing 1,471 to 1,485 of 2,281 entries